Theravance Biopharma, Inc. Quarterly Return On Assets in % from Q3 2014 to Q3 2024

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Theravance Biopharma, Inc. quarterly/annual Return On Assets history and growth rate from Q3 2014 to Q3 2024.
  • Theravance Biopharma, Inc. Return On Assets for the quarter ending September 30, 2024 was -13.4 %, a 18.1% decline year-over-year.
  • Theravance Biopharma, Inc. annual Return On Assets for 2023 was -12.4 %, a 107% decline from 2022.
  • Theravance Biopharma, Inc. annual Return On Assets for 2022 was 167 %.
  • Theravance Biopharma, Inc. annual Return On Assets for 2021 was -50.4 %, a 2.5% increase from 2020.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q3 2024 -13.4 -2.06 -18.1% Jul 1, 2024 Sep 30, 2024
Q2 2024 -11.9 -159 -108% Apr 1, 2024 Jun 30, 2024
Q1 2024 -11.1 -165 -107% Jan 1, 2024 Mar 31, 2024
Q4 2023 -12.4 -180 -107% Oct 1, 2023 Dec 31, 2023
Q3 2023 -11.4 -195 -106% Jul 1, 2023 Sep 30, 2023
Q2 2023 147 +175 Apr 1, 2023 Jun 30, 2023
Q1 2023 154 +192 Jan 1, 2023 Mar 31, 2023
Q4 2022 167 +218 Oct 1, 2022 Dec 31, 2022
Q3 2022 183 +237 Jul 1, 2022 Sep 30, 2022
Q2 2022 -27.2 +32 +54.1% Apr 1, 2022 Jun 30, 2022
Q1 2022 -37.3 +19.9 +34.8% Jan 1, 2022 Mar 31, 2022
Q4 2021 -50.4 +1.29 +2.5% Oct 1, 2021 Dec 31, 2021
Q3 2021 -53.9 +0.68 +1.25% Jul 1, 2021 Sep 30, 2021
Q2 2021 -59.2 -5.82 -10.9% Apr 1, 2021 Jun 30, 2021
Q1 2021 -57.2 -6.6 -13% Jan 1, 2021 Mar 31, 2021
Q4 2020 -51.7 -1.33 -2.64% Oct 1, 2020 Dec 31, 2020
Q3 2020 -54.6 -11 -25.2% Jul 1, 2020 Sep 30, 2020
Q2 2020 -53.4 -7.93 -17.5% Apr 1, 2020 Jun 30, 2020
Q1 2020 -50.6 -3.25 -6.86% Jan 1, 2020 Mar 31, 2020
Q4 2019 -50.4 -3.33 -7.08% Oct 1, 2019 Dec 31, 2019
Q3 2019 -43.6 +15.3 +26% Jul 1, 2019 Sep 30, 2019
Q2 2019 -45.4 +11.4 +20% Apr 1, 2019 Jun 30, 2019
Q1 2019 -47.4 +11.1 +19% Jan 1, 2019 Mar 31, 2019
Q4 2018 -47 +8.39 +15.1% Oct 1, 2018 Dec 31, 2018
Q3 2018 -58.9 -11.8 -25% Jul 1, 2018 Sep 30, 2018
Q2 2018 -56.8 -13 -29.7% Apr 1, 2018 Jun 30, 2018
Q1 2018 -58.5 -14.8 -33.8% Jan 1, 2018 Mar 31, 2018
Q4 2017 -55.4 -9.58 -20.9% Oct 1, 2017 Dec 31, 2017
Q3 2017 -47.1 +3.7 +7.28% Jul 1, 2017 Sep 30, 2017
Q2 2017 -43.8 +15.5 +26.1% Apr 1, 2017 Jun 30, 2017
Q1 2017 -43.7 +20.1 +31.5% Jan 1, 2017 Mar 31, 2017
Q4 2016 -45.9 +16.3 +26.3% Oct 1, 2016 Dec 31, 2016
Q3 2016 -50.8 +15.9 +23.8% Jul 1, 2016 Sep 30, 2016
Q2 2016 -59.3 +3.38 +5.4% Apr 1, 2016 Jun 30, 2016
Q1 2016 -63.8 -4.28 -7.19% Jan 1, 2016 Mar 31, 2016
Q4 2015 -62.2 +18.4 +22.9% Oct 1, 2015 Dec 31, 2015
Q3 2015 -66.7 +33.7 +33.6% Jul 1, 2015 Sep 30, 2015
Q2 2015 -62.6 Apr 1, 2015 Jun 30, 2015
Q1 2015 -59.5 Jan 1, 2015 Mar 31, 2015
Q4 2014 -80.6 Oct 1, 2014 Dec 31, 2014
Q3 2014 -100 Jul 1, 2014 Sep 30, 2014
* An asterisk sign (*) next to the value indicates that the value is likely invalid.